Biotech
10x Genomics
10x Genomics raises $55M Series E at $500M valuation
$55M
Total Raised
Series E
Latest Round
2012
Founded
800+
Employees
Pleasanton, CA
1 min read
Quick Facts
Valuation
$500M
Latest Round Size
$55M
Latest Round Date
January 2018
10x Genomics: Series E Funding Round
10x Genomics has successfully raised $55M in Series E funding, reaching a valuation of $500M.
Company Overview
Single-cell genomics and spatial biology
Funding Details
The Series E round was led by Softbank Vision Fund, with participation from Fidelity.
Company Information
- Headquarters: Pleasanton, CA
- Founded: 2012
- Employees: 800+
- Category: Biotech
Investment
10x Genomics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Softbank Vision Fund: Verified investor in Series E
- Fidelity: Verified investor in Series E
Key Investors
Softbank Vision Fund
Lead Investor
Verified investor in Series E
Fidelity
Investor
Verified investor in Series E
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M